Cohort 3a and 3b: Chondrosarcoma

specific

An aggressive morphologic variant of chondrosarcoma. It is composed of a low grade chondrosarcoma and a high grade non-cartilagenous sarcomatous component. Due to the aggressive nature of the disease, its prognosis is poor.

11

Centers

0

Active Trials

—

Cancer Funding

Top Centers for Cohort 3a and 3b: Chondrosarcoma(11)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
54.5
2
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
54.5
3
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
54.5
4
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
54.5
5
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
54.5
6
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
54.5
7
Medical College of Wisconsin Cancer CenterMilwaukee, WI
54.5
8
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
54.5
9
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
54.5
10
University of Illinois Cancer CenterChicago, IL
54.5
11
Boston University Cancer CenterBoston, MA
54.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →